
    
      This is an open-label, multi-center, prospective, postmarket study to assess the safety and
      effectiveness of EVOLENCEÂ® (DP101) in Subjects with Fitzpatrick Skin Color Types IV, V, and
      VI seeking correction of bilateral facial wrinkles and folds of the nasolabial area.

      The study will enroll and treat a total of 165 subjects with Fitzpatrick Skin Color Types IV,
      V and VI who have clinical evidence of moderate to deep bilateral wrinkles in the nasolabial
      area.
    
  